ICM
DINO icon

Invenomic Capital Management’s HF Sinclair DINO Stock Holding History

Invenomic Capital Management’s Portfolio DINO Stock Details DINO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-160,031
Closed -$5.26M – 161
2025
Q1 		$5.26M Sell
160,031
-94,084
-37% -$3.3M 0.27% 110
2024
Q4 		$8.91M Buy
+254,115
New +$10.4M 0.42% 79
2022
Q2 		– Sell
-35,477
Closed -$1.41M – 157
2022
Q1 		$1.41M Buy
+35,477
New +$1.25M 0.15% 118

Other funds holding DINO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invenomic Capital Management's DINO Position: Q2 2025 in Review

Invenomic Capital Management sold out of HF Sinclair (DINO) in Q2 2025, closing a stake of 160,031 shares — an estimated $5.26M sold.

Invenomic Capital Management first reported a position in DINO in Q1 2022 and held it in 3 quarters. The position peaked at $8.91M in Q4 2024. 542 funds tracked by Wall St. Rank hold DINO as of Q2 2025.

  • Invenomic Capital Management reported no remaining HF Sinclair position as of Q2 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 160,031 HF Sinclair shares in Q2 2025, an estimated $5.26M.
  • Invenomic Capital Management first reported a position in HF Sinclair in Q1 2022 and held it in 3 quarters.
  • Invenomic Capital Management's HF Sinclair position peaked at $8.91M in Q4 2024.
  • 542 funds tracked by Wall St. Rank held HF Sinclair as of Q2 2025.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.